Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare and
heterogeneous but treatable immune-mediated neuropathy. Nerve conduction studies are …

Background Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by
inflammation of the peripheral nerves, which corticosteroids would be expected to benefit …

Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …

ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Background: Consensus guidelines on the definition, investigation, and treatment of chronic
inflammatory demyelinating polyradiculoneuropathy (CIDP) have been published (J …

Background Short-term studies suggest that intravenous immunoglobulin might reduce
disability caused by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) but …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
chronic progressive or relapsing and remitting disease that usually causes weakness and …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes
progressive or relapsing weakness and numbness of the limbs, which lasts for at least two …

Since the discovery of an acute monophasic paralysis, later coined Guillain–Barré
syndrome, almost 100 years ago, and the discovery of chronic, steroid-responsive …

Данные клинические рекомендации подготовлены совместно с Всероссийской
ассоциацией для больных муковисцидозом, рассмотрены и утверждены на заседании …